Kevin Sek (@kevin_sek) 's Twitter Profile
Kevin Sek

@kevin_sek

ID: 898107986719129600

calendar_today17-08-2017 09:03:24

14 Tweet

45 Takipçi

175 Takip Edilen

A/Prof Paul Beavis (@paulbeavis4) 's Twitter Profile Photo

Happy to share our latest review, written by Kevin Sek on the interplay between adenosine and adoptive cellular therapy, 2 topics of high interest to our lab. This issue of Current Opinion in Pharmacology has many great papers on adenosine in cancer. authors.elsevier.com/a/1bdSW5Ea-8H4…

Lev Kats (@levkats) 's Twitter Profile Photo

Thinking about PhD or Honours? We’ll work with you to design a research project that fits your interests and the skills you want to learn within one of our themes. Join me for a chat at the open day

Miguel Reina-Campos (@mreinacampos) 's Twitter Profile Photo

A discrete population of CD8 T cells that bridge the gap between effector and memory subsets - Terminal Tem - Really glad I got to contribute to this story by Goldrath Lab Justin Milner - thanks to Cancer Research Institute - check it out > pnas.org/content/early/…

Harvey Lab (@harveyhippolab) 's Twitter Profile Photo

Cells use their machinery to multitask. Here Jonathan Pojer finds 2 parts of the Hippo Swiss army knife that control cell fate as well as organ growth. First 1st author paper for Jonathan - congratulations! Peter Mac Research Monash Biomedicine Discovery Institute biorxiv.org/content/10.110…

ACIR (@acir_org) 's Twitter Profile Photo

SPOTLIGHT: IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors Peter Mac Cancer Centre Prof Paul Beavis Originally published in Molecular Therapy To read our summary click bit.ly/ObaLongISIM and scroll all the way down.

SPOTLIGHT: IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors <a href="/PeterMacCC/">Peter Mac Cancer Centre</a> <a href="/paulbeavis4/">Prof Paul Beavis</a> Originally published in <a href="/MolTherapy/">Molecular Therapy</a> To read our summary click bit.ly/ObaLongISIM and scroll all the way down.
A/Prof Paul Beavis (@paulbeavis4) 's Twitter Profile Photo

We are currently looking for a post doc to join our team. Project will investigate a new approach to enhance CAR T in solid tumours through engagement of host immunity. Australian and New Zealand Society for Immunology Peter Mac Research Junyun Lai petermac.mercury.com.au/ViewPosition.a…

Jack Chan (@jack_chan15) 's Twitter Profile Photo

Here's my @IAmSciComm - On a Break! schedule for next week! I'll be focusing on #film, #video and moving media, so hit me up if you need to make video or if you're movie buff yourself! 🎥x🧪

Here's my <a href="/iamscicomm/">@IAmSciComm - On a Break!</a> schedule for next week! I'll be focusing on #film, #video and moving media, so hit me 
up if you need to make video or if you're movie buff yourself! 🎥x🧪
Pear Review Club (@pearreviewclub) 's Twitter Profile Photo

We're back babyyy with an all new episode for the Lunar New Year! Join us as we try and figure out the science behind those health myths our Asian parents told us! #CNY2021 #CNY #science #scicomm #AcademicChatter #phdchat open.spotify.com/episode/11Iwij…

A/Prof Paul Beavis (@paulbeavis4) 's Twitter Profile Photo

Interested in working on developing CAR T cells & strategies to improve their trafficking? We are now hiring for a research assistant perfect for someone wanting to develop skills working alongside one of the best Imran. Closes 19th March. Link👇 Peter Mac Research Australian and New Zealand Society for Immunology

Ian Parish (@ianparish_au) 's Twitter Profile Photo

Ever wondered how a T cell decides to be anergic vs exhausted? We identify the anergy-associated transcription factor Egr2 as a key regulator of CD8+ T cell exhaustion, with some surprising results that may answer this question. Take home messages below(1/)nature.com/articles/s4146…

A/Prof Paul Beavis (@paulbeavis4) 's Twitter Profile Photo

Very proud to share the latest work from the lab. This work describes a new methodology to enhance the activity of CAR T in solid tumours through CRISPR- mediated deletion of the adenosine A2AR nature.com/articles/s4146…